Sickling Test for Sickle Cell Detection at Chughtai Lab

Sickling Test at Chughtai Lab

The Sickling Test at Chughtai Lab is a highly specialized hematological screening investigation designed to identify the presence of abnormal hemoglobin S (HbS) in the blood. Hemoglobin is the vital iron-rich protein contained within red blood cells (erythrocytes) responsible for transporting oxygen from the lungs to all tissues and organs of the body. In healthy individuals, the predominant form of this protein is Hemoglobin A (HbA), which allows red blood cells to maintain a highly flexible, biconcave disc shape. This unique structural flexibility enables erythrocytes to squeeze smoothly through the narrowest capillaries of the microcirculation. However, individuals carrying a specific genetic mutation in the HBB gene produce Hemoglobin S. Under conditions of reduced oxygen tension (hypoxia), these abnormal HbS molecules polymerize into rigid, tactile fibers that distort the cell membrane, forcing the red blood cells to assume a rigid, crescent, or “sickle” shape.

At Chughtai Lab, the sickling test is performed using advanced, evidence-based laboratory techniques, primarily the sodium metabisulfite sickling preparation. By introducing a chemical reducing agent to the blood sample, the laboratory technologists artificially induce a state of low oxygen tension. The sample is then carefully evaluated under high-resolution light microscopy to observe whether the red blood cells undergo characteristic sickling deformation. This test is of paramount clinical importance, particularly in regions like Pakistan where hemoglobinopathies and genetic blood disorders are highly prevalent. It serves as an essential, cost-effective primary screening tool to identify individuals who may be carriers of the sickle cell trait (heterozygous state, HbAS) or those suffering from sickle cell disease (homozygous state, HbSS, or compound heterozygous states such as HbS-beta thalassemia).

Early and accurate identification of abnormal hemoglobin variants is crucial for preventing life-threatening complications. The diagnostic value of the sickling test lies in its ability to quickly alert clinicians to the presence of HbS, allowing for timely intervention, genetic counseling, and the formulation of long-term management plans. By choosing Chughtai Lab, patients benefit from a highly standardized testing environment, experienced hematologists, and rapid reporting, ensuring that clinical decisions can be made with the utmost confidence and precision.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the clinical accuracy and reliability of the sickling test results. Patients are advised to adhere to the following guidelines prior to their blood collection at Chughtai Lab:

• No Fasting Required: There is no requirement for dietary fasting before undergoing a sickling test. Patients can eat and drink normally prior to the procedure.
• Disclose Recent Blood Transfusions: It is absolutely critical to inform the laboratory staff and your prescribing physician if you have received a blood transfusion within the last 3 to 4 months. Transfused normal red blood cells (containing HbA) can temporarily dilute the proportion of abnormal HbS cells in your bloodstream, potentially leading to a false-negative result.
• Provide Medical History: Inform the healthcare provider about any history of severe anemia, recent painful crises, or if you are currently undergoing treatment for a known hemoglobinopathy.
• Hydration: Ensure adequate hydration by drinking plenty of water before the test. Well-hydrated veins are easier to access, making the venipuncture process quicker and more comfortable.
• Clothing: Wear comfortable clothing with sleeves that can be easily rolled up above the elbow to facilitate access to the venipuncture site.

During the Procedure

The sickling test requires a standard peripheral blood sample, which is collected by a highly trained phlebotomist at Chughtai Lab. The procedure is quick, safe, and involves the following steps:

• Patient Positioning: The patient is asked to sit comfortably in a dedicated blood collection chair. The phlebotomist will ask the patient to extend their arm, resting it on a stable support.
• Site Selection and Cleansing: The phlebotomist examines the patient’s arm to locate a suitable vein, typically the median cubital vein in the antecubital fossa (inner elbow). Once selected, the skin over the vein is thoroughly cleansed with a sterile 70% isopropyl alcohol swab using a circular motion and allowed to air dry completely.
• Tourniquet Application: A soft elastic tourniquet is tied around the upper arm, a few inches above the collection site. This temporarily restricts venous blood flow, causing the veins to swell and become more visible and palpable.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube holder is gently inserted into the vein. The phlebotomist collects the blood into an EDTA (ethylenediaminetetraacetic acid) tube, which contains an anticoagulant to prevent the blood from clotting.
• Tourniquet Release and Needle Withdrawal: As the tube fills with the required volume of blood (approximately 2 to 3 milliliters), the tourniquet is released to restore normal circulation. The needle is then smoothly withdrawn from the vein.
• Post-Puncture Care: Immediate, gentle pressure is applied to the puncture site using a sterile cotton ball or gauze pad to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then applied over the site.
• Newborn Collection: For newborns and infants, the sample may be collected via a heel prick (capillary blood collection) rather than venipuncture, ensuring minimal discomfort for the baby.
• Sample Processing: The collected blood sample is immediately labeled with the patient’s unique barcode and sent to the hematology laboratory, where a reducing agent is added to a drop of blood on a slide, sealed to exclude oxygen, and examined under a microscope at specific intervals.

When is a Sickling Test Performed?

Evaluation of Unexplained Hemolytic Anemia

Physicians frequently request a sickling test when a patient presents with clinical signs of chronic hemolytic anemia. This condition is characterized by the premature destruction of red blood cells, far exceeding the bone marrow’s capacity to produce new ones. Symptoms such as persistent fatigue, generalized weakness, unexplained jaundice (yellowish discoloration of the skin and sclera), and dark-colored urine warrant immediate investigation. The sickling test helps clinicians determine whether abnormal hemoglobin S is the underlying cause of this accelerated erythrocyte destruction.

Investigation of Vaso-Occlusive Crises and Severe Pain

A hallmark clinical manifestation of sickle cell disease is the occurrence of vaso-occlusive crises, which cause sudden, excruciating pain in the bones, joints, abdomen, or chest. These crises occur when rigid, sickled red blood cells obstruct microvascular blood flow, leading to tissue ischemia and localized infarction. When a patient presents to an emergency department or clinic with these acute symptoms, a sickling test is performed as a rapid screening tool to identify the presence of sickling-prone hemoglobin, facilitating immediate and appropriate clinical management.

Pre-Marital and Family Screening

In regions with a high prevalence of genetic hemoglobin disorders, pre-marital screening is a vital public health strategy. The sickling test is widely utilized to screen prospective couples to determine if either partner carries the sickle cell trait (HbAS). If both partners are carriers, there is a 25% risk with each pregnancy of having a child with sickle cell disease (HbSS). Performing this test allows couples to receive comprehensive genetic counseling and make informed decisions regarding family planning.

Screening of Newborns and Infants

Early detection of sickle cell disorders in newborns and infants is critical for reducing morbidity and mortality. Infants born to parents who are known carriers, or infants presenting with failure to thrive, recurrent dactylitis (painful swelling of the hands and feet), or frequent infections, are candidates for screening. Identifying sickle cell disease early in life allows healthcare providers to initiate prophylactic penicillin therapy and administer essential vaccinations to protect against life-threatening pneumococcal infections.

Assessment of Recurrent Infections and Splenomegaly

Children and young adults with sickle cell disease often experience progressive damage to the spleen due to recurrent microvascular infarctions, eventually leading to functional asplenia (loss of splenic function). This leaves them highly vulnerable to severe infections caused by encapsulated bacteria. A physician may order a sickling test when evaluating a patient who presents with recurrent, severe bacterial infections accompanied by splenomegaly (an enlarged spleen) to rule out underlying sickle cell pathology.

What Does a Sickling Test Detect?

The sickling test is highly sensitive to the physical properties of Hemoglobin S under hypoxic conditions. It detects and assists in the clinical evaluation of several parameters, including:

• The presence of abnormal Hemoglobin S (HbS) within the erythrocytes.
• The physical deformation of red blood cells into crescent or sickle shapes under low oxygen tension.
• The carrier state of sickle cell trait (heterozygous HbAS).
• The homozygous state of sickle cell disease (HbSS).
• The presence of compound heterozygous states, such as Hemoglobin S-C disease (HbSC).
• The presence of Hemoglobin S-beta thalassemia.
• Erythrocyte morphological abnormalities induced by reducing agents like sodium metabisulfite.
• The underlying genetic cause of chronic hemolytic anemia.
• The potential risk for microvascular vaso-occlusive events.
• The risk of splenic sequestration crises in pediatric patients.
• Susceptibility to acute chest syndrome, a life-threatening pulmonary complication.
• The underlying cause of pediatric dactylitis (hand-foot syndrome).
• The risk of developing avascular necrosis of the femoral or humeral head.
• The predisposition to priapism caused by microvascular sludging of sickled cells.
• The etiology of chronic, non-healing leg ulcers in young adults.
• The cause of unexplained hematuria, which can occur even in individuals with sickle cell trait.
• The risk of proliferative sickle retinopathy leading to visual impairment.
• The potential for functional asplenia and subsequent susceptibility to encapsulated bacterial infections.
• The presence of target cells (codocytes) on a peripheral blood smear.
• The presence of Howell-Jolly bodies, indicating splenic hypofunction.
• The risk of stroke or transient ischemic attacks, particularly in pediatric sickle cell patients.
• The carrier status of family members of an index patient diagnosed with sickle cell disease.
• The clinical necessity for confirmatory Hemoglobin Electrophoresis.
• The clinical necessity for High-Performance Liquid Chromatography (HPLC) testing.
• The requirement for definitive genetic testing of the HBB gene.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its commitment to operational excellence, utilizing advanced laboratory automation and robust quality assurance protocols to deliver highly accurate results. The turnaround time (TAT) for a routine Sickling Test is exceptionally efficient, with reports typically finalized and verified by a consultant pathologist within 12 to 24 hours of sample collection.

To enhance patient convenience, Chughtai Lab offers multiple seamless methods for accessing diagnostic reports. Once the analysis is complete, patients receive an automated SMS notification on their registered mobile number containing a direct link to view their results. Reports can also be securely accessed and downloaded in PDF format via the official Chughtai Lab website or the user-friendly Chughtai Lab mobile application. For those who prefer physical documentation, printed reports can be collected from any of the numerous Chughtai Lab collection centers located conveniently across Pakistan.

Sickling Test Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Red Blood Cell Morphology (Hypoxic State)	No sickling observed; cells retain round, biconcave shape	Classic sickle-shaped (crescent) cells present
Hemoglobin Type Present	Predominantly Hemoglobin A (HbA)	Presence of Hemoglobin S (HbS)
Clinical Status	Normal (No sickle cell gene mutation detected)	Sickle Cell Trait (Carrier) or Sickle Cell Disease
Peripheral Blood Smear (Uninduced)	Normal normochromic, normocytic red blood cells	Presence of sickled cells, target cells, and Howell-Jolly bodies
Hemoglobin Levels	Within normal reference range	Decreased levels (anemia), typically 6-8 g/dL in sickle cell disease
Reticulocyte Count	Normal (0.5% – 2.5%)	Elevated reticulocyte count (indicative of active bone marrow response to hemolysis)
Serum Bilirubin	Normal total and indirect bilirubin levels	Elevated indirect bilirubin (due to accelerated breakdown of red blood cells)
Lactate Dehydrogenase (LDH)	Normal levels	Significantly elevated LDH (marker of intravascular hemolysis)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Sickling Test?

• Experienced healthcare professionals: Our laboratory is staffed by highly qualified medical technologists and overseen by consultant pathologists specializing in hematology.
• Patient-focused care: We prioritize patient comfort and safety, ensuring a gentle and professional blood collection experience for patients of all ages.
• Quality diagnostic services: Chughtai Lab adheres to stringent international standards of quality control, ensuring high accuracy and reliability in every test result.
• Professional reporting: Our reports are comprehensive, clear, and structured to provide clinicians with the precise diagnostic insights they need.
• Modern diagnostic approach: We utilize state-of-the-art automated hematology analyzers and high-resolution microscopy for sample evaluation.
• Comfortable environment: All our diagnostic centers are designed to provide a clean, hygienic, and welcoming atmosphere for patients.
• Convenient locations: With a vast network of collection centers across Pakistan, finding a Chughtai Lab facility near you is incredibly easy.
• Commitment to accurate diagnosis: We understand the critical role of diagnostic accuracy in patient care and are dedicated to delivering results you can trust.